Ulcerative colitis (UC) is an idiopathic inflammatory bowel disease. It is an interaction between including genetic, immunological, reactive oxygen species, and environmental factors, which affects the large intestine. It is clinically characterized by diarrhea, abdominal pain or rectal pain, fever, weight loss, and blood in the stool.\[[@ref1]\] Although UC is most commonly detected in young adulthood,\[[@ref2]\] the condition can affect patients of any age and both genders. Also this disease affects women slightly more than men.\[[@ref3]\] Loftus *et al*. reported that the incidence of UC is about 10--20 per 10^6^ per year with a prevalence of 100--200 per 10^6^ in Western countries.\[[@ref4]\] Overall, the rate of UC is higher in developed countries than in developing countries due to their lifestyle,\[[@ref5]\] whereas it is increasing in Iran\[[@ref6]\] and Taiwan.\[[@ref7]\]

It is suggested that environmental conditions are more effective than genetics. Other factors such as intestinal microflora, mucosal immune response, autoimmune reactions, and especially oxidative stress are also important in the pathophysiology of UC.\[[@ref8]\] Medical and surgical therapies are the current modalities for treatment of UC, but surgery is indicated for those who are unresponsive to medical therapy. Although bacterial bowel flora such as *Shigella*, *Clostridium difficile*, and *Escherichia coli* 0157:H7 may be one of the contributing factors in the pathogenesis of chronic mucosal inflammation, antibiotics treatment has no established role in UC.\[[@ref9]\]

The use of no effectiveness of usual treatments, the use of alternative medicines, mainly of herbal treatments, for UC is increasing.\[[@ref10]\] The effects of many medicinal plants in UC have been investigated in the past decades. These include Strawberry,\[[@ref11]\] *Vitex negund*,\[[@ref12]\] licorice,\[[@ref13][@ref14]\] *Ginkgo biloba*,\[[@ref15]\] *Oroxylum indicu*,\[[@ref1]\] *Origanum onites*,\[[@ref16]\] and *Calendula officinalis*\[[@ref17][@ref18]\] in rats, *Polygonum multiflorum* in mice,\[[@ref19]\] *Fragaria vesca*\[[@ref20]\] and *Moringa olifera* in albino rats,\[[@ref12]\] *Teucrium polium*\[[@ref21]\] and *Calendula Officinalis* in dog,\[[@ref22]\] and *C. officinalis* in mice.\[[@ref23]\]

*C. officinalis*, also known as Marigold, is an annual herb native to the Mediterranean region,\[[@ref24]\] and an important medicinal plant in the family *Asteraceae*. In traditional medicine, it is used for the treatment of fever and cancer.\[[@ref25]\] It is hypothesized to be effective in treating this disease due to its antioxidant\[[@ref26][@ref27][@ref28]\] and anti-inflammatory\[[@ref29][@ref30]\] compounds. *C. officinalis* extract decreases lipid peroxidation and inhibits edema. It is also used for gastrointestinal,\[[@ref28]\] gynecological, eye, and skin diseases.\[[@ref31]\] The plant is rich in several pharmaceutically active ingredients such as sterols, flavonoids, carotenoids, and glycosides.\[[@ref32]\]

This study has been undertaken to compare the effects of oral and enema forms of hydroalcohol extract of *C. Officinalis* on improvement of acetic acid-induced UC in adult male rats.

MATERIALS AND METHODS {#sec1-1}
=====================

Plant materials {#sec2-1}
---------------

*C. officinalis* was collected from Abadeh of Fars province in Iran (GPS coordinates: 31.160833,52.650556) during the spring season. All plants were in the flowering stage and the taxonomic identification of each plant was confirmed by a Specialized Botanist. The plant also matched the digital herbarium of Botanical Garden and Botanical Museum Berlin-Dahlem, Freie University, Berlin (<http://herbarium.bgbm.org/object/BW16687040> and <http://ww2.bgbm.org/herbarium/>(Barcode: B -W 16687 -02 0/Image Id: 397152). This plant also was recorded in the herbarium of Pharmacology Department, Shiraz University of Medical Sciences, Shiraz, Iran, as herbarium number: 763.

Preparation of hydroalcoholic extract {#sec2-2}
-------------------------------------

Hydroalcoholic extract was prepared from *C. officinalis* flowers by Pharmacology Department of Shiraz University of Medical Sciences according to the previous reports.\[[@ref33][@ref34][@ref35][@ref36][@ref37][@ref38][@ref39][@ref40][@ref41]\] *C. officinalis* flowers were collected from Fars province (southwest of Iran). Flowers were shade-dried in the laboratory at ambient temperature of 25--30°C and relative humidity. Then, dried flowers were powdered in a mechanical grinder and soaked in adequate volume of ethanol: Water (80:20) solution for 72 h using percolation method. The extract was filtered and evaporated in a rotary evaporator under reduced pressure then dried in temperature of 50°C for 72 h and stored at −20°C.

Animals and housing {#sec2-3}
-------------------

Totally 96 Sprague--Dawley male rats, weighing 200 ± 20 g, were obtained from Laboratory Animal Center of Shiraz University of Medical Sciences. The animals were housed in a restricted-access room under controlled environment (22 ± 1°C, 55% relative humidity, and 12:12 h light--dark cycle) for seven days as acclimation with access to water and feed *ad libitum*. The study protocol was approved by the Ethics Committee of Shiraz University of Medical Sciences (registration number: 90-5077).

UC induction {#sec2-4}
------------

Acetic acid was used for induction of UC according to a previous report.\[[@ref36]\] All rats were fasted overnight and induction was done using a soft catheter, where the tip of the catheter inserted up to 8 cm proximal to the anus after removing distal stools. UC was induced by transrectal administration of 1 mL of 3% acetic acid. The rats were maintained in head down position for 30 s to prevent leakage.

Experimental grouping {#sec2-5}
---------------------

Rats were randomly divided into eight equal groups and different treatments were applied daily as following:

Group I (negative control 1) received 1 ml/kg of normal saline orallyGroup II (negative control 2) received 1 ml/kg of base gel intracolonicGroup III (positive control 1) received 10 mg/kg of asacol intracolonicGroup IV (positive control 2) received 10 mg/kg of mesalamine orallyGroup V received the 10% *C. officinalis* extract in the gel form, intracolonicGroup VI received the 20% *C. officinalis* extract in the gel form, intracolonicGroup VII received 1500 mg/kg of *C. officinalis* extract orallyGroup VIII received 3000 mg/kg of *C. officinalis* extract orally.

The 1500 and 300 mg/kg oral form of *C. officinalis* extract were given other than food in the form of syrup by gavage every morning, at 8 o'clock.

Base gel was (100 g) produced by dissolving 1 g of carboxymethyl cellulose and 9 g glycin in 90 mL of deionized water. Their weight was also recorded daily, and percentage of weight change was calculated using the following formula:
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Myeloperoxidase activity {#sec2-6}
------------------------

On the 3^rd^ day after starting the treatment, half of the animals from each group were randomly selected to take blood samples directly from their heart under inhaled anesthesia in order to measure the activity of myeloperoxidase (MPO) in the serum. After blood sampling, the animals were euthanized for histopathological study. The study same procedure was followed on the 7^th^ day after starting the treatment. MPO activity can be measured in tissues by assays using hydrogen peroxide and *o*-dianisidine dihydrochloride as substrates.\[[@ref37]\]

Malondialdehyde level {#sec2-7}
---------------------

Obtained tissues were stored under liquid nitrogen and then tissue malondialdehyde (MDA) assessment was performed. In this procedure the measurement of thiobarbituric acid reactive substances in PBS tissue homogenate was performed,\[[@ref38]\] because MDA is one of the end products of lipid peroxidation (LPO), and the extent of LPO is most frequently measured by estimating MDA levels.\[[@ref39]\] There are different indicators for oxidative stress that show tissue lipid peroxidation. Due to available laboratory instruments, MPO and MDA (LPO indicators) were evaluated.

Histopathological evaluation {#sec2-8}
----------------------------

Half of the animals from each group were randomly selected and euthanized by ether inhalation on day 3 after induction of colitis and half of them after 7 days. Abdomens were opened using a surgical scissor. Colonic tissue was studied histopathologically as described in previous reports.\[[@ref40][@ref41][@ref42][@ref43][@ref44]\] For each rat, the distal 8 cm portion of the colon was immediately removed,\[[@ref36]\] free of surrounding fat, and fixed in 10% buffered formalin for histopathological examination. Formalin-fixed tissues were processed routinely and embedded in paraffin. Blocks were cut at 5 μm, and sections were stained with hematoxylin--eosin. All sections were studied and photographed by a light microscope.

Statistical analysis {#sec2-9}
--------------------

The data were expressed as means ± SD. Differences between groups were carried out by one-way ANOVA and Tukey HSD *post hoc* test. Pathological data were evaluated using Mann--Whitney test. All statistical analyses were done by SPSS software (Version 20) and Excel Office program (Version 10). Differences at *P* \< 0.05 were considered significant.

RESULTS {#sec1-2}
=======

Hydroalcoholic extraction of the dried flowers of *C. officinalis* yielded 18.19 g dried extract in 100 g of dried powder. Therefore, the efficiency of our extraction procedure was 18.19%. Significant difference was seen in weight change between all treatment groups in comparison with negative control and base gel groups at the end of experiment (*P* \< 0.05). the most statistical differences were observed in *C. officinalis* extract at a dose of 3000 mg/kg orally, mesalamine (oral) and 20% intracolonic gel form of marigold extract, respectively \[[Figure 1](#F1){ref-type="fig"}\]. Changes in histopathological features of the colonic tissue after induction of UC and 7 days of treatment by *C. officinalis* extract as a dose of as 20% intracolonic gel and 3000 mg/kg orally are presented in [Figure 2](#F2){ref-type="fig"}. Also, [Table 1](#T1){ref-type="table"} shows histopathological assessment of colonic tissue after different treatments post-induction of UC in rats on days 3 and 7. Acute inflammation and granular atrophy after UC induction were resolved completely by both 20% intracolonic gel and 3000 mg/kg orally. Histopathological scoring varied and includes no damage, mild, moderate, and severe damage with a score of 0--4, respectively. MPO activity of different groups in 3 and 7 days after treatment is presented in [Figure 3](#F3){ref-type="fig"}. MPO activity on 3 days after administration of *C. officinalis* extract at 1500 and 3000 mg/kg orally, 10%, 20% intracolonic gel form, asacol (enema), and mesalamine (oral) significantly decreased (*P* \< 0.05) when compared with negative control groups 1 and 2. Also MPO activity on day 3 PT in groups, which had received 20% intracolonic gel form and 3000 mg/kg orally revealed a significant increase in comparison to asacol (*P* \< 0.05). MPO activity on 7 days after administration of *C. officinalis* extract (3000 mg/kg) orally, 20% intracolonic gel form, and mesalamine significantly decreased as compared with both the negative control groups similar to that of administration of asacol, oral form of *C. officinalis* extract (1500 mg/kg) and 10% intracolonic gel form (*P* \< 0.05). Also, there was a significant increase for MPO activity on day 7. PT in groups were given 20% intracolonic gel forms when compared with mesalamine, asacol, 20% intracolonic gel forms and *C. officinalis* extract as 3000 mg/kg orally (*P* \< 0.05).

![Percentage of mean weight changes in different groups during seven days after ulcerative colitis induction](SJG-22-50-g002){#F1}

![Histopathological changes associated with experimental ulcerative colitis induction and treatment with *Calendula officinalis* extract. (a), healthy colon; (b), acute inflammation and granular atrophy in response to acetic acid 3%; (c), 20% gel of *C. officinalis* extract in enema rout; (d), 3000 mg/kg of *C. officinalis* extract, orally (H and E, ×400)](SJG-22-50-g003){#F2}

###### 

Histopathologic assessment of colonic tissue after treatment of oral and enema forms of hydroalcohol extract of marigold post-induction of UC in rats in the third and seventh days (mean±SD, *n*=6)
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![Changes of myeloperoxidase (MPO) activity in different groups at 3 and 7 days after induction of ulcerative colitis. Significant differences between groups at day 3 and 7 were indicated by different capital and lowercase letters, respectively (*P* \< 0.05)](SJG-22-50-g005){#F3}

MDA level changes in different groups on 3^rd^ and 7^th^ day after treatment are presented in [Figure 4](#F4){ref-type="fig"}. As demonstrated, MDA level in base gel treatment group was significantly lower than normal saline-treated group on both 3^rd^ and 7^th^ days after treatment (*P* \< 0.05). Also, MDA levels on on the 3^rd^ and 7^th^ days after administration of *C. officinalis* extract orally in both doses, 10% intracolonic gel form, asacol (enema), and mesalamine (orally) significantly decreased (*P* \< 0.05) when compared with both negative control groups (*P* \< 0.05). Other significant differences between different treatment groups are presented in [Figure 4](#F4){ref-type="fig"}.

![Changes of malondialdehyde (MDA) level in different groups at 3 and 7 days after induction of ulcerative colitis. Significant differences between groups at day 3 and 7 were indicated by different capital and lowercase letters, respectively (*P* \< 0.05)](SJG-22-50-g006){#F4}

DISCUSSION {#sec1-3}
==========

In the present study, the healing effects of *C. officinalis* extract as oral and intracolonic administration in acid-induced UC were evaluated and compared with normal saline, base gel, and standard treatments. Our results demonstrated that there were clear differences between groups that received hydroalcohol extract of *C. officinalis* with negative control groups, although they were similar to positive control groups.

UC increases the inflammatory cells and free radicals with severe oxidative stress. MPO and MDA, inflammatory mediators, are two factors to evaluate oxidative stress. MPO is used as a marker enzyme for measuring polymorphonuclear leukocytes and has been used as a quantitative index of inflammation in several tissues, including the intestine.\[[@ref45]\] MDA and MPO are indicators of lipid peroxidation. So the high amount of MPO and MDA is due to the severity of inflammation, lipid peroxidation, and tissue damage.\[[@ref46]\] Measuring of MPO activity and MDA level showed that *C. officinalis* extract in the two forms of oral and transrectal administration and in different doses on is more effective than negative control and base gel groups in decreasing of inflammation in acetic acid-induced UC but similar to the asacol (transrectal)-treated group. In the present study, by using of *C. officinalis* extract orally and intracoloniclly, the decrease in the MPO and MDA activity occurs with the decrease in lipid peroxidation. This may be due to decline in the inflammation and neutrophil accumulation in the inflamed intestine. These findings were in agreement with results of Preethi *et al*.\[[@ref30]\] that *C. officinalis* extract by oral administration acted as anti-inflammatory in reduction of paw edema and inflammation in mice and confirmed by Preethi *et al*.\[[@ref27]\] that the oral administration of *C. officinalis* extract acts as antioxidant inhibited lipid peroxidation in mice tissues and also scavenged free radicals.

*C. officinalis* extract possessed flavonoids, flavoxanthin, saponins, triterpiniod esters, and auroxanthin, and that by blocking the arachidonic acid pathway and inhibiting mechanisms of MPO and MDA, it induces its anti-inflammatory and antioxidant properties.\[[@ref26][@ref27][@ref29][@ref30][@ref32][@ref47]\] Due to these, *C. officinalis* extract could prevent colitis. Triterpenoids, by increasing the transcriptional activity of nuclear factor erythroid-derived 2)-like 2 (NRF2), which induces the formation of superoxide dismutase and catalase, keep tissues from oxidative stress.\[[@ref12]\]

Histopathological study showed that *C. officinalis* extract could induce a significant improvement in healing of UC while that of oral (3000 mg/kg) and gel form (20%, trans-rectal) had similar effects with mesalamine (oral) due to high proliferation of epithelial cells. In negative control and base gel groups, reduction of epithelial cells, granulation tissues, and healing were significantly obvious when compared with others. Histological changes of this study in control groups were in agreement with results of Tanideh *et al*.\[[@ref11]\] in rats and Mehrabani *et al*.\[[@ref22]\] in dogs with acetic acid-induced UC, respectively. The histopathological analyses of UC also give the evidence of the increased healing potential of the *C. officinalis* extract due to its ability to decrease acute phase proteins. In addition, some histopathological factors such as cyst, inflammatory cells, edema, and abscess in group were given 3000 mg/kg of *C. officinalis* extract (oral form) were at least among all experimental groups, which approved that of authority to reduce inflammation. Vasodilation in negative control and base gel groups was more than others, whereas it was at least in group were given 3000 mg/kg of *C. officinalis* extract (oral form). Also this showed the potency of *C. officinalis* extract to degrade inflammation due to its flavonoids\[[@ref48]\] and triterpiniod\[[@ref47]\] compounds.

Microscopic findings such as mucosal and submucosal erosion, acute inflammation, and granular epithelial necrosis were seen in colon tissues of negative control groups more than others. But those which received the extract, inflammation was low and erosion was limited to the mucosa. Interestingly, healing effects of transrectal gel form (20%) and oral administration (3000 mg/kg) of *C. officinalis* extract were significantly more in comparison to control groups similar to mesalamine orally. Mehrabani *et al*.\[[@ref22]\] reported similar results after administration of *C. officinalis* that caused significant mucosal healing in dogs with UC.

CONCLUSION {#sec1-4}
==========

This study demonstrated that the daily application of *C. officinalis* extract in gel form or by oral administration can relieve the UC induced by acetic acid in the colon of rat. Results for tissue MDA level and MPO activity plus histopathological evaluations indicated a reduction in inflammation. Studies are required to assess if this agent would be of potential benefit in humans.
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